Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.verified

OPNT

Price:

$20.65

Market Cap:

$108.80M

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

Industry

Biotechnology

IPO Date

2007-06-04

Stock Exchange

NASDAQ

Ticker

OPNT

The Enterprise Value as of November 2025 (TTM) for Opiant Pharmaceuticals, Inc. (OPNT) is 88.02M

According to Opiant Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 88.02M. This represents a change of 28.32% compared to the average of 68.60M of the last 4 quarters.

Opiant Pharmaceuticals, Inc. (OPNT) Historical Enterprise Value (quarterly & annually)

How has OPNT Enterprise Value performed in the past?

The mean historical Enterprise Value of Opiant Pharmaceuticals, Inc. over the last ten years is 44.62M. The current 88.02M Enterprise Value has changed 19.63% with respect to the historical average. Over the past ten years (40 quarters), OPNT's Enterprise Value was at its highest in in the December 2021 quarter at 129.08M. The Enterprise Value was at its lowest in in the September 2020 quarter at 1.15M.

Quarterly (TTM)
Annual

Average

44.62M

Median

43.55M

Minimum

4.86M

Maximum

129.08M

Opiant Pharmaceuticals, Inc. (OPNT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Opiant Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.56%

Maximum Annual Enterprise Value = 129.08M

Minimum Annual Increase = -82.43%

Minimum Annual Enterprise Value = 4.86M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2021129.08M2.56%
20204.86M-82.43%
201927.65M49.30%
201818.52M-62.08%
201748.84M-5.15%
201651.50M3.62%
201549.70M3.36%
201448.08M23.21%
201339.02M34.87%
201228.93M56.23%

Opiant Pharmaceuticals, Inc. (OPNT) Average Enterprise Value

How has OPNT Enterprise Value performed in the past?

The current Enterprise Value of Opiant Pharmaceuticals, Inc. (OPNT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

53.86M

5-year avg

45.79M

10-year avg

44.62M

Opiant Pharmaceuticals, Inc. (OPNT) Enterprise Value vs. Peers

How is OPNT’s Enterprise Value compared to its peers?

Opiant Pharmaceuticals, Inc.’s Enterprise Value is greater than Cyteir Therapeutics, Inc. (-37516738.00), greater than RVL Pharmaceuticals plc (16.09M), greater than HilleVax, Inc. (69.63M), less than Tourmaline Bio, Inc. (1.20B), greater than Jounce Therapeutics, Inc. (-41597260.00), less than Miromatrix Medical Inc. (91.30M), less than Decibel Therapeutics, Inc. (102.82M), less than Graybug Vision, Inc. (115.07M), less than Paratek Pharmaceuticals, Inc. (351.99M), greater than Aadi Bioscience, Inc. (-24287393.00),

Build a custom stock screener for Opiant Pharmaceuticals, Inc. (OPNT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opiant Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opiant Pharmaceuticals, Inc. (OPNT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opiant Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Opiant Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Opiant Pharmaceuticals, Inc. (OPNT)?

What is the 3-year average Enterprise Value for Opiant Pharmaceuticals, Inc. (OPNT)?

What is the 5-year average Enterprise Value for Opiant Pharmaceuticals, Inc. (OPNT)?

How does the current Enterprise Value for Opiant Pharmaceuticals, Inc. (OPNT) compare to its historical average?